Figure 1.
Flowchart of the study design.
* Early revascularizations within 90 days after CCTA were censored at the time of PCI or CABG.
Table 1.
Baseline characteristics of the study population.
Table 2.
Cox regression analysis of cardiac biomarkers for the composite endpoint of cardiac events.
Figure 2.
Kaplan-Meier analyses illustrating improved classification by including hs-cTnT to current risk stratification tools.
Figures on the left shows Kaplan-Meier curves for FRS (A), CCS (C) and CCTA assessment (E). Figures on the right shows Kaplan-Meier curves when hs-cTnT was added to FRS (B), CCS (D) and CCTA assessment (F). Q4 = fourth quartile of hs-cTnT concentrations.
Table 3.
Cox regression analysis of Framingham risk profiling for the composite endpoint of cardiac events.
Table 4.
Cox regression analysis of coronary plaque assessment for the composite endpoint of cardiac events.